The 2025 Wynn Signature Chinese Wine Awards Judging Week Commences at the End of February

The 2025 Wynn Signature Chinese Wine Awards Judging Week Commences at the End of February

The 6-day event features higher competition standards with an elevated panel of 27 acclaimed judges, plus a series of events including wine seminars, Masterclasses, and wine dinners MACAO, Feb. 25, 2025 /PRNewswire/ -- With the support of the Macao...

Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs

Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs

HONG KONG, Feb. 25, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab, Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a clinical trial collaboration with Pfizer Inc....

China-ASEAN Observation: What role does China play in the renewed blue economy dynamism?

China-ASEAN Observation: What role does China play in the renewed blue economy dynamism?

BEIJING, Feb. 24, 2025 /PRNewswire/ -- When we talked about Brunei Darussalam, a small sultanate in Southeast Asia, the first idea that comes across our minds would be the fact that it is a petro-state with a Gross Domestic Product (GDP) of 47%...

Agility: As Risks Loom, Logistics Execs Say They've Rewired Supply Chains

Agility: As Risks Loom, Logistics Execs Say They've Rewired Supply Chains

Industry looks to shield itself from trade wars, inflation, possible recession DUBAI, UAE, Feb. 18, 2025 /PRNewswire/ -- More than 62% of logistics industry professionals say they've overhauled their supply chains to safeguard against inflation,...

Dubai to Gather More Than 30 Heads of State and Government, Global Leaders at the World Governments Summit 2025

Dubai to Gather More Than 30 Heads of State and Government, Global Leaders at the World Governments Summit 2025

Delegations from 140 governments, global tech leaders gather in Dubai on February 11-13 to accelerate solutions for the world's greatest challenges Among notable guests – 30 heads of state and governments, the Managing Director of IMF, CEOs of...

LightInTheBox Receives Non-compliance Letter from NYSE Regarding Market Capitalization

LightInTheBox Receives Non-compliance Letter from NYSE Regarding Market Capitalization

SINGAPORE, Jan. 24, 2025 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global online retailer focusing on proprietary apparel brands and design-driven collections tailored to evolving consumer...

XDS Shoes: How to Find a Shoe Manufacturer

XDS Shoes: How to Find a Shoe Manufacturer

JINJIANG, China, Jan. 14, 2025 /PRNewswire/ -- With the rising demand for high-quality footwear and private-label customization, finding the right shoe manufacturer has become a critical challenge for businesses in the industry. XDS Shoes, a leading...

"Better Design Award"-- Creating the Best Design, Achieving a Better Life

"Better Design Award"-- Creating the Best Design, Achieving a Better Life

GUANGZHOU, China, Dec. 17, 2024 /PRNewswire/ -- On May 22, 2024, the global promotion event of "Better Design Award" (abbreviated as BDA) was held magnificently in Guangzhou, China. BDA is an international comprehensive design competition accessible...

Skyhawk Therapeutics Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington's Disease Patient Trial

Skyhawk Therapeutics Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington's Disease Patient Trial

Australian Human Research Ethics Committees approves SKY-0515 treatment for up to 12 weeks in the company's ongoing Phase 1 trial in patients with Huntington's Disease Volumetric MRI measurement is also approved as exploratory study endpoint BOSTON,...

GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment

GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment

YONGIN, South Korea, Nov. 26, 2024 /PRNewswire/ -- GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new drug for Sanfillippo syndrome type A...

  • 1
  • 2
  • menu
    menu